EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation

Jianmin Gu, Shaoyuan Zhang, Dong Lin, Wenhan Wang, Jinke Cheng, Quan Zheng, Hao Wang, Lijie Tan

Cellular Oncology · 2025

DOI: 10.1007/s13402-024-00956-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Jianmin Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Sumoylation, Esophageal Neoplasms, Cysteine Endopeptidases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Doctor Project of Zhongshan Hospital Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Esophageal squamous cell carcinoma (ESCC) is a prevalent tumor in the gastrointestinal tract, but our understanding of the molecular mechanisms underlying ESCC remains incomplete. Existing studies indicate that SUMO specific peptidase 1 (SENP1) plays a crucial role in the development and progression of various malignant tumors through diverse molecular mechanisms. However, the functional mechanism and clinical implications of SENP1 in the progression of ESCC remain unclear.

Methods

Bulk RNA-Sequencing (RNA-seq) was used to compare potential genes in the esophageal tissues of mice with ESCC to the control group. The up-regulated SENP1 was selected. The protein level of SENP1 in ESCC patient samples was analyzed by immunohistochemistry and western blot. The potential prognostic value of SENP1 on overall survival of ESCC patients was examined using tissue microarray analysis and the Kaplan-Meier method. The biological function was confirmed through in vitro and in vivo knockdown approaches of SENP1. The role of SENP1 in cell cycle progression and apoptosis of ESCC cells was analyzed by flow cytometry and western blot. The downstream signaling pathways regulated by SENP1 were investigated via using RNA-Seq. SENP1-associated proteins were identified through immunoprecipitation. Overexpression of Sirtuin 6 (SIRT6) wildtype and mutant was performed to investigate the regulatory role of SENP1 in ESCC progression in vitro.

Results

Our study discovered that SENP1 was upregulated in ESCC tissues and served as a novel prognostic factor. Moreover, SENP1 enhanced cell proliferation and migration of ESCC cell lines in vitro, as well as promoted tumor growth in vivo. Thymidine kinase 1 (TK1), Geminin (GMNN), cyclin dependent kinase 1(CDK1), and cyclin A2 (CCNA2) were identified as downstream genes of SENP1. Mechanistically, SENP1 deSUMOylated SIRT6 and subsequently inhibited SIRT6-mediated histone 3 lysine 56 (H3K56) deacetylation on those downstream genes. SIRT6 SUMOylation mutant (4KR) rescued the growth inhibition upon SENP1 depletion.

Conclusions

SENP1 promotes the malignant progression of ESCC by inhibiting the deacetylase activity of SIRT6 pathway through deSUMOylation. Our findings suggest that SENP1 may serve as a valuable biomarker for prognosis and a target for therapeutic intervention in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaSumoylationEsophageal NeoplasmsCysteine EndopeptidasesSirtuinsHumansCell Line, TumorCell ProliferationAnimalsGene Expression Regulation, NeoplasticFemaleApoptosisMiceMaleMice, NudePrognosisSignal Transduction

Stichwörter der Autor:innen

Cell cycleEsophageal squamous cell carcinomaSENP1SIRT6SUMOylation

Substanzen

SENP1 protein, humanCysteine EndopeptidasesSirtuinsSIRT6 protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200080, China.
  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Center for Singl-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. tczq0236@sjtu.edu.cn.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. wang.hao@zs-hospital.sh.cn.
  • Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. tan.lijie@zs-hospital.sh.cn.

Förderung

  • Excellent Doctor Project of Zhongshan Hospital Fudan University

Zitieren

APA

Gu, J., Zhang, S., Lin, D., Wang, W., Cheng, J., Zheng, Q., Wang, H., & Tan, L. (2025). Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation. Cellular Oncology. https://doi.org/10.1007/s13402-024-00956-4

Vancouver

Gu J, Zhang S, Lin D, Wang W, Cheng J, Zheng Q, et al. Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation. Cellular Oncology. 2025. doi:10.1007/s13402-024-00956-4

BibTeX
@article{Gu2025,
  author = {Gu, Jianmin and Zhang, Shaoyuan and Lin, Dong and Wang, Wenhan and Cheng, Jinke and Zheng, Quan and Wang, Hao and Tan, Lijie},
  title = {Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-024-00956-4}
}
Kostenlos starten →